The human decidual NK-cell response to virus infection: What can we learn from circulating NK lymphocytes?

Journal of Reproductive Immunology

Volumn 88, Issue 2, 2011, Pages 170-175

  Le Bouteiller, Philippe ^a,b   Siewiera, Johan ^a,b   Casart, Ysabel ^a,b   Aguerre Girr, Maryse ^a,b   El Costa, Hicham ^a,b   Berrebi, Alain ^a,c   Tabiasco, Julie ^a,b   Jabrane Ferrat, Nabila ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c Paul Sabatier University   (France)

Author keywords

Decidual NK cells; NK cell receptors; Pregnancy; Virus infection

Indexed keywords

CD16 ANTIGEN; CD48 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; CD94 ANTIGEN; GAMMA INTERFERON; GRANULYSIN; GRANZYME A; GRANZYME B; HLA E ANTIGEN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2A; PERFORIN; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN;

ARTICLE; CELL ACTIVATION; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOTOXICITY; EPSTEIN BARR VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NATURAL KILLER CELL; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; VIRUS INFECTION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; BLOOD CIRCULATION; CYTOTOXICITY, IMMUNOLOGIC; DECIDUA; FEMALE; HUMANS; IMMUNE EVASION; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; PLACENTAL CIRCULATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRUS DISEASES;

EID: 79952698448     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2010.12.005     Document Type: Article

References (63)

1. Achdout H., Manaster I., Mandelboim O. Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins. J. Virol. 2008, 82:8030-8037.
2. Apps R., Gardner L., Traherne J., Male V., Moffett A. Natural-killer cell ligands at the maternal-fetal interface: UL-16 binding proteins, MHC class-I chain related molecules. HLA-F and CD48. Hum. Reprod. 2008, 23:2535-2548.
3. Barakonyi A., Rabot M., Marie-Cardine A., Aguerre-Girr M., Polgar B., Schiavon V., Bensussan A., Le Bouteiller P. Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset. J. Immunol. 2004, 173:5349-5354.
4. Bryceson Y.T., March M.E., Ljunggren H.G., Long E.O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 2006, 107:159-166.
5. Bulmer J.N., Williams P.J., Lash G.E. Immune cells in the placental bed. Int. J. Dev. Biol. 2010, 54:281-294.
6. Carlino C., Stabile H., Morrone S., Bulla R., Soriani A., Agostinis C., Bossi F., Mocci C., Sarazani F., Tedesco F., Santoni A., Gismondi A. Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy. Blood 2008, 111:3108-3115.
7. Cerwenka A., Lanier L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 2001, 1:41-49.
8. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P.D., Wu L., Mackay C.R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85:1135-1148.
9. De Maria A., Fogli M., Mazza S., Basso M., Picciotto A., Costa P., Congia S., Mingari M.C., Moretta L. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur. J. Immunol. 2007, 37:445-455.
10. Derrien M., Faye A., Dolcini G., Chaouat G., Barre-Sinoussi F., Menu E. Impact of the placental cytokine-chemokine balance on regulation of cell-cell contact-induced human immunodeficiency virus type 1 translocation across a trophoblastic barrier in vitro. J. Virol. 2005, 79:12304-12310.
11. El Costa H., Casemayou A., Aguerre-Girr M., Rabot M., Berrebi A., Parant O., Clouet-Delannoy M., Lombardelli L., Jabrane-Ferrat N., Rukavina D., Bensussan A., Piccinni M.-P., Le Bouteiller P., Tabiasco J. Critical and differential roles of NKp46- and NKp30-activating receptors expressed by uterine NK cells in early pregnancy. J. Immunol. 2008, 181:3009-3017.
12. El Costa H., Tabiasco J., Berrebi A., Parant O., Aguerre-Girr M., Piccinni M.P., Le Bouteiller P. Effector functions of human decidual NK cells in healthy early pregnancy are dependent on the specific engagement of natural cytotoxicity receptors. J. Reprod. Immunol. 2009, 82:142-147.
13. Fauci A.S., Mavilio D., Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat. Rev. Immunol. 2005, 5:835-843.
14. Goodridge J.P., Lathbury L.J., John E., Charles A.K., Christiansen F.T., Witt C.S. The genotype of the NK cell receptor, KIR2DL4, influences INFgamma secretion by decidual natural killer cells. Mol. Hum Reprod. 2009, 15:489-497.
15. Griffin B.D., Verweij M.C., Wiertz E.J. Herpesviruses and immunity: the art of evasion. Vet. Microbiol. 2010, 143:89-100.
16. Guma M., Angulo A., Vilches C., Gomez-Lozano N., Malats N., Lopez-Botet M. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 2004, 104:3664-3671.
17. Guma M., Budt M., Saez A., Brckalo T., Hengel H., Angulo A., Lopez-Botet M. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006, 107:3624-3631.
18. Hanna J., Goldman-Wohl D., Hamani Y., Avraham I., Greenfield C., Natanson-Yaron S., Prus D., Cohen-Daniel L., Arnon T.I., Manaster I., Gazit R., Yutkin V., Benharroch D., Porgador A., Keshet E., Yagel S., Mandelboim O. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 2006, 12:1065-1074.
19. Hanna J., Gonen-Gross T., Fitchett J., Rowe T., Daniels M., Arnon T.I., Gazit R., Joseph A., Schjetne K.W., Steinle A., Porgador A., Mevorach D., Goldman-Wohl D., Yagel S., LaBarre M.J., Buckner J.H., Mandelboim O. Novel APC-like properties of human NK cells directly regulate T cell activation. J. Clin. Invest. 2004, 114:1612-1623.
20. Hanna J., Wald O., Goldman-Wohl D., Prus D., Markel G., Gazit R., Katz G., Haimov-Kochman R., Fujii N., Yagel S., Peled A., Mandelboim O. CXCL12 expression by invasive trophoblasts induces the specific migration of CD16-human natural killer cells. Blood 2003, 102:1569-1577.
21. Hershkovitz O., Rosental B., Rosenberg L.A., Navarro-Sanchez M.E., Jivov S., Zilka A., Gershoni-Yahalom O., Brient-Litzler E., Bedouelle H., Ho J.W., Campbell K.S., Rager-Zisman B., Despres P., Porgador A. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J. Immunol. 2009, 183:2610-2621.
22. Hershkovitz O., Zilka A., Bar-Ilan A., Abutbul S., Davidson A., Mazzon M., Kummerer B.M., Monsoengo A., Jacobs M., Porgador A. Dengue virus replicon expressing the nonstructural proteins suffices to enhance membrane expression of HLA class I and inhibit lysis by human NK cells. J. Virol. 2008, 82:7666-7676.
23. Jonjic S., Babic M., Polic B., Krmpotic A. Immune evasion of natural killer cells by viruses. Curr. Opin. Immunol. 2008, 20:30-38.
24. Kalkunte S.S., Mselle T.F., Norris W.E., Wira C.R., Sentman C.L., Sharma S. Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J. Immunol. 2009, 182:4085-4092.
25. King A., Birkby C., Loke Y.W. Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast. Cell Immunol. 1989, 118:337-344.
26. Koopmann J.O., Hammerling G.J., Momburg F. Generation, intracellular transport and loading of peptides associated with MHC class I molecules. Curr. Opin. Immunol. 1997, 9:80-88.
27. Kopcow H.D., Allan D.S., Chen X., Rybalov B., Andzelm M.M., Ge B., Strominger J.L. Human decidual NK cells form immature activating synapses and are not cytotoxic. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15563-15568.
28. Kuijpers T.W., Baars P.A., Dantin C., van den Burg M., van Lier R.A., Roosnek E. Human NK cells can control CMV infection in the absence of T cells. Blood 2008, 112:914-915.
29. Lanier L.L. NK cell recognition. Annu. Rev. Immunol. 2005, 23:225-274.
30. Lash G.E., Robson S.C., Bulmer J.N. Review: Functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta 2010, 31(Suppl.):S87-92.
31. Le Bouteiller P., Barakonyi A., Giustiniani J., Lenfant F., Marie-Cardine A., Aguerre-Girr M., Rabot M., Hilgert I., Mami-Chouaib F., Tabiasco J., Boumsell L., Bensussan A. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:16963-16968.
32. Le Bouteiller P., Sargent I. HLA class I molecules in the placenta: Which ones? Where? and What for? A workshop report. Placenta 2000, 21(Suppl. A):S93-S96.
33. Le Bouteiller P., Tabiasco J. Killers become builders during pregnancy. Nat. Med. 2006, 12:991-992.
34. Lee S.H., Kim K.S., Fodil-Cornu N., Vidal S.M., Biron C.A. Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J. Exp. Med. 2009, 206:2235-2251.
35. Markel G., Wolf D., Hanna J., Gazit R., Goldman-Wohl D., Lavy Y., Yagel S., Mandelboim O. Pivotal role of CEACAM1 protein in the inhibition of activated decidual lymphocyte functions. J. Clin. Invest. 2002, 110:943-953.
36. Marlin R., Nugeyre M.T., de Truchis C., Berkane N., Gervaise A., Barre-Sinoussi F., Menu E. Antigen-presenting cells represent targets for R5 HIV-1 infection in the first trimester pregnancy uterine mucosa. PLoS One 2009, 4:e5971.
37. Mela C.M., Burton C.T., Imami N., Nelson M., Steel A., Gazzard B.G., Gotch F.M., Goodier M.R. Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy. Aids 2005, 19:1761-1769.
38. Moffett-King A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2002, 2:656-663.
39. Moffett A., Regan L., Braude P. Natural killer cells, miscarriage, and infertility. Br. Med. J. 2004, 329:1283-1285.
40. Mselle T.F., Howell A.L., Ghosh M., Wira C.R., Sentman C.L. Human uterine natural killer cells but not blood natural killer cells inhibit human immunodeficiency virus type 1 infection by secretion of CXCL12. J. Virol. 2009, 83:11188-11195.
41. Orr M.T., Murphy W.J., Lanier L.L. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat. Immunol. 2010, 11:321-327.
42. Pereira L., Maidji E., McDonagh S., Tabata T. Insights into viral transmission at the uterine-placental interface. Trends Microbiol. 2005, 13:164-174.
43. Rabot M., El Costa H., Polgar B., Marie-Cardine A., Aguerre-Girr M., Barakonyi A., Valitutti S., Bensussan A., Le Bouteiller P. CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment. Int. Immunol. 2007, 19:401-409.
44. Rajagopalan S., Moyle M.W., Joosten I., Long E.O. DNA-PKcs controls an endosomal signaling pathway for a proinflammatory response by natural killer cells. Sci. Signal. 2010, 3:ra14.
45. Rukavina D., Podack E.R. Abundant perforin expression at the maternal-fetal interface: guarding the semiallogeneic transplant?. Immunol. Today 2000, 21:160-163.
46. Saito S. Cytokine network at the feto-maternal interface. J. Reprod. Immunol. 2000, 47:87-103.
47. Saito S., Nakashima A., Myojo-Higuma S., Shiozaki A. The balance between cytotoxic NK cells and regulatory NK cells in human pregnancy. J. Reprod. Immunol. 2008, 77:14-22.
48. Santoni A., Zingoni A., Cerboni C., Gismondi A. Natural killer (NK) cells from killers to regulators: distinct features between peripheral blood and decidual NK cells. Am. J. Reprod. Immunol. 2007, 58:280-288.
49. Scott-Algara D., Arnold V., Didier C., Kattan T., Pirozzi G., Barre-Sinoussi F., Pancino G. The CD85j+ NK cell subset potently controls HIV-1 replication in autologous dendritic cells. PLoS One 2008, 3:e1975.
50. Tabiasco J., Rabot M., Aguerre-Girr M., El Costa H., Berrebi A., Parant O., Laskarin G., Juretic K., Bensussan A., Rukavina D., Le Bouteiller P. Human decidual NK cells: unique phenotype and functional properties-a review. Placenta 2006, 27(Suppl. A):S34-39.
51. Ulbrecht M., Martinozzi S., Grzeschik M., Hengel H., Ellwart J.W., Pla M., Weiss E.H. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol. 2000, 164:5019-5022.
52. Vacca P., Cantoni C., Prato C., Fulcheri E., Moretta A., Moretta L., Mingari M.C. Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells. Int. Immunol. 2008, 20:1395-1405.
53. Vacca P., Pietra G., Falco M., Romeo E., Bottino C., Bellora F., Prefumo F., Fulcheri E., Venturini P.L., Costa M., Moretta A., Moretta L., Mingari M.C. Analysis of natural killer cells isolated from human decidua: evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function. Blood 2006, 108:4078-4085.
54. van Stijn A., Rowshani A.T., Yong S.L., Baas F., Roosnek E., ten Berge I.J., van Lier R.A. Human cytomegalovirus infection induces a rapid and sustained change in the expression of NK cell receptors on CD8+ T cells. J. Immunol. 2008, 180:4550-4560.
55. Verma S., Hiby S.E., Loke Y.W., King A. Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol. Reprod. 2000, 62:959-968.
56. Vermijlen D., Brouwer M., Donner C., Liesnard C., Tackoen M., Van Rysselberge M., Twite N., Goldman M., Marchant A., Willems F. Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J. Exp. Med. 2010, 207:807-821.
57. Vivier E., Tomasello E., Baratin M., Walzer T., Ugolini S. Functions of natural killer cells. Nat. Immunol. 2008, 9:503-510.
58. Waggoner S.N., Taniguchi R.T., Mathew P.A., Kumar V., Welsh R.M. Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis. J. Clin. Invest. 2010, 120:1925-1938.
59. Wilkinson G.W., Tomasec P., Stanton R.J., Armstrong M., Prod'homme V., Aicheler R., McSharry B.P., Rickards C.R., Cochrane D., Llewellyn-Lacey S., Wang E.C., Griffin C.A., Davison A.J. Modulation of natural killer cells by human cytomegalovirus. J. Clin. Virol. 2008, 41:206-212.
60. Williams P.J., Searle R.F., Robson S.C., Innes B.A., Bulmer J.N. Decidual leucocyte populations in early to late gestation normal human pregnancy. J. Reprod. Immunol. 2009, 82:24-31.
61. Yokoyama W.M., Altfeld M., Hsu K.C. Natural killer cells: tolerance to self and innate immunity to viral infection and malignancy. Biol. Blood Marrow Transpl. 2010, 16:S97-S105.
62. Zafirova B., Mandaric S., Antulov R., Krmpotic A., Jonsson H., Yokoyama W.M., Jonjic S., Polic B. Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity 2009, 31:270-282.
63. Zhang J., Chen Z., Smith G.N., Croy B.A. Natural killer cell-triggered vascular transformation: maternal care before birth?. Cell. Mol. Immunol. 2010, 10.1038/cmi.2010.38.